Increased platelet residual activity in patients treated with acetosalicylic acid is associated with increased tissue factor and decreased tissue factor pathway inhibitor plasma levels-Reference-Cited by-同舟云学术

Increased platelet residual activity in patients treated with acetosalicylic acid is associated with increased tissue factor and decreased tissue factor pathway inhibitor plasma levels

Published:2011-02 Issue:3 Volume:146 Page:479-481
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Vojacek Jan,Sevcikova Hana,Sevcik Robert,Bis Josef,Pecka Miroslav

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?;Altman;Thromb J,2004

2. Immune versus thrombotic stimulation of platelets differentially regulates signaling pathways, intracellular protein-protein interactions, and alpha-granule release;Rex;Thromb Haemost,2009

3. Expression of Toll-like receptors on human platelets;Shiraki;Thromb Res,2004

4. The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting;Gurbel;Platelets,2009

5. Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin;Poston;Transfusion,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should We Replace the Terms Intrinsic and Extrinsic Coagulation Pathways With Tissue Factor Pathway?;Clinical and Applied Thrombosis/Hemostasis;2016-10-18

2. Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid;Journal of Thrombosis and Haemostasis;2014-10-15

3. Clinical monitoring of the antithrombotic treatment;Cor et Vasa;2012-03-01

4. Good Short-Term but not Long-Term Reproducibility of the Antiplatelet Efficacy Laboratory Assessment;Clinical and Applied Thrombosis/Hemostasis;2011-09-23